United Health Products, Inc.

UEECdata completeness 75%16 fiscal years on file

Data notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own

Figure	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	$59¹	$37,500²	$0³	$0⁴	$0⁴
Net income	−$30.5M⁵	−$1.69M⁶	−$2.62M⁷	−$2M⁸	−$2.67M⁸
Operating cash flow	−$828,079⁹	−$619,720¹⁰	−$2.2M¹¹	−$1.19M¹²	−$1.19M¹²
Capital expenditure	$0¹³	—	—	—	—
Free cash flow (derived)	−$828,079⁹	—	—	—	—
Total debt	—	—	—	—	—
Cash & equivalents	$21,799¹⁴	$13,377¹⁴	$95,420¹⁵	$168,883¹⁵	$65,249¹⁵
Diluted shares	228.7M	230.9M	239.1M	248.2M	257.0M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal

If you owned

Net assets behind them

−$0.15

your share of equity

Profit it earned you last year

−$0.1

Free cash flow it threw off

—

Debt you’d be carrying

—

10 shares is a claim on −$0.15 of net worth that earned you −$0.1 last year.

iii. Is this a good business?

Moat signal · return on equity

— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →

Management signal · capital allocation

+12% shares · 5y

Share count is up 12% over 5 years — owners have been diluted. Worth asking what they got for it.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0

DCF · Growth Exit 10Y

not applicable

only 2 years of FCF (need ≥3) — model not applicable

DCF · Growth Exit 5Y

not applicable

only 2 years of FCF (need ≥3) — model not applicable

Earnings Power Value

not applicable

normalized (5y-median) earnings non-positive — EPV undefined

Graham Number

not applicable

diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts

10-K · period ending 2021-12-31 · accession 0001477932-23-001788 (Revenues)
10-K · period ending 2022-12-31 · accession 0001477932-24-001671 (Revenues)
10-K · period ending 2023-12-31 · accession 0001477932-25-002110 (Revenues)
10-K · period ending 2024-12-31 · accession 0001477932-26-002286 (Revenues)
10-K · period ending 2021-12-31 · accession 0001477932-23-001788 (NetIncomeLoss)
10-K · period ending 2022-12-31 · accession 0001477932-24-001671 (NetIncomeLoss)
10-K · period ending 2023-12-31 · accession 0001477932-25-002110 (NetIncomeLoss)
10-K · period ending 2024-12-31 · accession 0001477932-26-002286 (NetIncomeLoss)
10-K · period ending 2021-12-31 · accession 0001477932-23-001788 (NetCashProvidedByUsedInOperatingActivities)
10-K · period ending 2022-12-31 · accession 0001477932-24-001671 (NetCashProvidedByUsedInOperatingActivities)
10-K · period ending 2023-12-31 · accession 0001477932-25-002110 (NetCashProvidedByUsedInOperatingActivities)
10-K · period ending 2024-12-31 · accession 0001477932-26-002286 (NetCashProvidedByUsedInOperatingActivities)
10-K · period ending 2021-12-31 · accession 0001477932-22-001949 (PaymentsToAcquirePropertyPlantAndEquipment)
10-K · period ending 2021-12-31 · accession 0001477932-23-001788 (CashAndCashEquivalentsAtCarryingValue)
10-K · period ending 2023-12-31 · accession 0001477932-26-002286 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)